HUMA
Price
$2.12
Change
-$0.10 (-4.50%)
Updated
Jun 27 closing price
Capitalization
327.3M
51 days until earnings call
RXRX
Price
$5.03
Change
-$0.37 (-6.85%)
Updated
Jun 27 closing price
Capitalization
2.04B
44 days until earnings call
Interact to see
Advertisement

HUMA vs RXRX

Header iconHUMA vs RXRX Comparison
Open Charts HUMA vs RXRXBanner chart's image
Humacyte
Price$2.12
Change-$0.10 (-4.50%)
Volume$7.26M
Capitalization327.3M
Recursion Pharmaceuticals
Price$5.03
Change-$0.37 (-6.85%)
Volume$46.63M
Capitalization2.04B
HUMA vs RXRX Comparison Chart in %
Loading...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HUMA vs. RXRX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUMA is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (HUMA: $2.12 vs. RXRX: $5.03)
Brand notoriety: HUMA and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HUMA: 178% vs. RXRX: 190%
Market capitalization -- HUMA: $327.3M vs. RXRX: $2.04B
HUMA [@Biotechnology] is valued at $327.3M. RXRX’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HUMA’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • HUMA’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HUMA’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • HUMA’s TA Score: 3 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than HUMA.

Price Growth

HUMA (@Biotechnology) experienced а -8.23% price change this week, while RXRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

HUMA is expected to report earnings on Aug 19, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.04B) has a higher market cap than HUMA($327M). RXRX YTD gains are higher at: -25.592 vs. HUMA (-58.020). HUMA has higher annual earnings (EBITDA): -59.97M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. HUMA (62.8M). HUMA has less debt than RXRX: HUMA (15.8M) vs RXRX (92.9M). RXRX has higher revenues than HUMA: RXRX (59.8M) vs HUMA (517K).
HUMARXRXHUMA / RXRX
Capitalization327M2.04B16%
EBITDA-59.97M-524.77M11%
Gain YTD-58.020-25.592227%
P/E RatioN/AN/A-
Revenue517K59.8M1%
Total Cash62.8M500M13%
Total Debt15.8M92.9M17%
TECHNICAL ANALYSIS
Technical Analysis
HUMARXRX
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
84%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRKZF21.96N/A
N/A
Greek Organisation of Football Prognostics SA
TCOR0.60N/A
N/A
TreeCon Resources, Inc.
LIFZF20.76-0.16
-0.75%
Labrador Iron Ore Royalty Corp.
DSKYF22.46-0.44
-1.92%
Daiichi Sankyo Co., Ltd.
SBMSF0.05-0.02
-24.00%
Danakali Ltd.

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with AURA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
-4.50%
AURA - HUMA
38%
Loosely correlated
-0.16%
ACRV - HUMA
37%
Loosely correlated
-8.40%
RXRX - HUMA
37%
Loosely correlated
-6.85%
MNMD - HUMA
37%
Loosely correlated
-2.82%
BDTX - HUMA
37%
Loosely correlated
-4.07%
More